SHBG: What This Test Actually Measures

At a glance
- Test name / Sex Hormone-Binding Globulin (SHBG), also called testosterone-estradiol binding globulin
- What it binds / Testosterone (high affinity), dihydrotestosterone (highest affinity), estradiol (moderate affinity)
- Normal range, adult men / 10 to 57 nmol/L (varies by lab; age-adjusted upper limit rises after 60)
- Normal range, adult women (pre-menopausal) / 18 to 144 nmol/L
- Key downstream calculation / Calculated free testosterone or Free Androgen Index (FAI = total T / SHBG x 100)
- Primary production site / Hepatocytes (liver parenchymal cells)
- Raises SHBG / Estrogens, thyroid hormone, aging, cirrhosis, low androgens, phenytoin
- Lowers SHBG / Insulin, androgens (including exogenous testosterone), obesity, hypothyroidism, glucocorticoids
- Why it matters clinically / Two patients can have identical total testosterone yet vastly different free testosterone if SHBG differs
- Ordering context / Always order alongside total testosterone; add LH, FSH, and estradiol for full androgen panel
What SHBG Actually Is
SHBG is a homodimeric glycoprotein secreted primarily by hepatocytes. Each subunit contains one high-affinity steroid-binding site, giving the dimer two binding pockets. At any moment, roughly 40 to 60% of circulating testosterone is bound tightly to SHBG, 38 to 54% is loosely bound to albumin, and only 1 to 3% is unbound, or "free." Androgens bound to SHBG are essentially inactive at androgen receptors.
The Three Fractions of Testosterone
Endocrinologists recognize three fractions of circulating testosterone:
- SHBG-bound testosterone. Tightly held. Not available to most tissues.
- Albumin-bound testosterone. Loosely held. Dissociates readily as blood passes through capillary beds, making this fraction bioavailable.
- Free testosterone. Unbound. Directly enters cells.
"Bioavailable testosterone" is the sum of fractions 2 and 3. Free testosterone is fraction 3 alone. Both calculations depend on knowing SHBG.
Why Total Testosterone Alone Is Insufficient
The Endocrine Society's 2018 clinical practice guideline on testosterone therapy states: "We recommend measurement of total testosterone as the initial diagnostic test, with follow-up measurement of free or bioavailable testosterone when SHBG is suspected to be abnormal." Endocrine Society Clinical Practice Guideline, 2018.
A 45-year-old man with a total testosterone of 420 ng/dL and an SHBG of 70 nmol/L may have a calculated free testosterone below 5 ng/dL, well inside the hypogonadal range. The same total testosterone paired with an SHBG of 20 nmol/L yields a free testosterone near 12 ng/dL. Same number on the report; completely different clinical picture.
How SHBG Is Synthesized and Regulated
The liver does not produce SHBG at a fixed rate. Hepatic SHBG gene expression responds to several hormonal signals, making SHBG a sensitive readout of metabolic and endocrine health.
Signals That Increase Hepatic SHBG Output
Estrogens are the strongest upregulators. Oral estradiol raises SHBG substantially more than transdermal estradiol because oral delivery produces a hepatic first-pass estrogen surge. One study in postmenopausal women found oral estradiol 1 mg/day raised SHBG by approximately 45% versus a 12% rise with equivalent transdermal doses.
Thyroid hormones also stimulate SHBG production. Hyperthyroidism consistently elevates SHBG, and the rise can be severe enough to suppress free testosterone into the symptomatic range even when total testosterone appears normal. This mechanism is well-documented in the literature.
Aging independently raises SHBG in men at roughly 1 to 2% per year after age 40, which partly explains why free testosterone falls faster than total testosterone across the male lifespan. This trajectory is described in the Baltimore Longitudinal Study of Aging.
Signals That Suppress Hepatic SHBG Output
Insulin is the most clinically significant suppressor of SHBG. Even modest degrees of insulin resistance reduce SHBG gene transcription. A cross-sectional analysis (N=1,316) in the Third National Health and Nutrition Examination Survey demonstrated a strong inverse correlation between fasting insulin and SHBG independent of total testosterone. NHANES III data, accessible via the NIH.
Exogenous androgens, including testosterone cypionate, testosterone enanthate, and oral anabolic steroids, suppress SHBG. This is partly why men on TRT often experience a disproportionate rise in free testosterone relative to the change in total testosterone: the injected androgen lowers SHBG, releasing additional bound hormone into the free fraction.
Obesity compounds insulin's effect. Adipose tissue amplifies insulin resistance, and visceral fat in particular correlates inversely with SHBG in both sexes. A meta-analysis of 27 studies confirmed the obesity-SHBG inverse relationship.
Normal SHBG Ranges
Reference intervals differ by sex, age, and laboratory assay method. The numbers below represent consensus ranges from major reference laboratories and endocrine guidelines, but always interpret against your specific lab's reference interval.
Men
| Age Group | Typical SHBG Range | |---|---| | 20 to 40 years | 10 to 40 nmol/L | | 41 to 60 years | 12 to 50 nmol/L | | 61+ years | 15 to 57 nmol/L |
Low SHBG in a man (<15 nmol/L in most labs) often signals insulin resistance, obesity, or exogenous androgen use. High SHBG (>57 nmol/L) in a man suggests aging, hyperthyroidism, liver disease, or estrogen excess. The AACE/ACE Hypogonadism Guidelines recommend SHBG measurement in all men with borderline total testosterone results.
Women
Women show wider normal ranges because the menstrual cycle, pregnancy, and oral contraceptives all shift SHBG dramatically. Pre-menopausal women on no hormonal contraception typically run 18 to 144 nmol/L. Women taking combined oral contraceptives can reach 300 to 400 nmol/L, which is one mechanism by which the pill reduces androgenic symptoms in polycystic ovary syndrome (PCOS). This pharmacological effect is reviewed in the Endocrine Society PCOS guideline.
Post-menopausal women off hormone therapy typically fall to 20 to 60 nmol/L as endogenous estrogen production declines.
The PCOS Context
In PCOS, SHBG is characteristically low. Hyperinsulinemia suppresses hepatic SHBG output, and lower SHBG means that even a modestly elevated total testosterone produces a much higher free androgen index. The Free Androgen Index (FAI = total testosterone in nmol/L divided by SHBG in nmol/L, multiplied by 100) above 4.5 in women carries diagnostic weight for androgen excess. The Androgen Excess and PCOS Society uses this threshold in its diagnostic framework.
Calculating Free Testosterone From SHBG
Direct measurement of free testosterone by equilibrium dialysis is the reference method, but it is expensive and not widely available. Calculated free testosterone using the Vermeulen formula is the validated alternative and correlates well (r = 0.97) with equilibrium dialysis in multiple validation studies. Vermeulen A, et al., JCEM 1999.
The Vermeulen calculation requires:
- Total testosterone (nmol/L or ng/dL, converted)
- SHBG (nmol/L)
- Albumin (assumed 4.3 g/dL if not measured, or use actual value)
Online calculators at major endocrine society websites (such as the ISSAM calculator) run the formula automatically. Most TRT and HRT platforms, including HealthRX, calculate this automatically from your panel results.
The Free Androgen Index as a Simpler Proxy
For clinical screening, especially in women, FAI is simpler. Divide total testosterone in nmol/L by SHBG in nmol/L and multiply by 100. An FAI above 4.5 in women or below 30 in men (with symptoms) may warrant further evaluation. The FAI is less precise than the Vermeulen calculation in men because albumin binding accounts for a larger proportion of bioavailable testosterone at higher total testosterone concentrations. This limitation is described by Ly LP and Handelsman DJ.
What High SHBG Means Clinically
A consistently high SHBG reduces bioavailable testosterone and estrogen, which may produce symptoms even when total levels appear adequate.
Symptoms Associated With High SHBG
In men, high SHBG can present with:
- Fatigue and reduced drive despite "normal" total testosterone
- Decreased libido and erectile dysfunction
- Loss of muscle mass over 6 to 12 months
- Mood changes, particularly low motivation
In women, high SHBG can reduce androgenic tone, contributing to low libido, reduced genital sensitivity, and fatigue. Women on oral estrogen-containing contraceptives or menopausal hormone therapy who develop these symptoms may have SHBG-mediated androgen suppression. This phenomenon was described by Goldstat R, et al. In Menopause.
Causes to Rule Out
When SHBG is above range, the differential includes:
- Hyperthyroidism (check TSH, free T4)
- Liver disease, particularly early hepatocellular injury raising hepatic output
- Oral estrogen or oral contraceptive use
- Anti-epileptic drugs, especially phenytoin and carbamazepine
- Anorexia nervosa or severe caloric restriction
- Primary hypogonadism with persistently low androgens
What Low SHBG Means Clinically
Low SHBG raises free testosterone and estradiol fractions. This sounds favorable but carries metabolic and cardiovascular implications.
Metabolic Risk Linked to Low SHBG
Low SHBG is an independent predictor of type 2 diabetes risk. The Women's Health Study (N=359 incident diabetes cases over 10 years) found that women in the lowest SHBG quartile had a relative risk of 6.5 for incident type 2 diabetes compared to the highest quartile, after adjustment for BMI and other confounders. Ding EL, et al., NEJM 2009.
In men, low SHBG is associated with the metabolic syndrome, non-alcoholic fatty liver disease, and elevated cardiovascular risk. A prospective cohort study from the MMAS (Massachusetts Male Aging Study) found low SHBG independently predicted incident metabolic syndrome over an 8.8-year follow-up. Kupelian V, et al., Diabetes Care 2006.
When Low SHBG Is Clinically Dangerous in TRT Patients
Men on testosterone replacement who develop very low SHBG (<10 nmol/L) may experience erythrocytosis more rapidly because the large free testosterone fraction accelerates erythropoietin-stimulated red cell production. Monitoring hematocrit every 3 to 6 months is standard of care in this group. The Endocrine Society TRT guideline specifies hematocrit thresholds for dose adjustment.
Causes to Rule Out
When SHBG is below range, consider:
- Insulin resistance or frank type 2 diabetes
- Obesity (BMI >30 is a common correlate)
- Hypothyroidism (check TSH)
- Exogenous androgen use, including testosterone therapy and anabolic steroids
- Glucocorticoid excess (endogenous Cushing's or exogenous steroid use)
- Nephrotic syndrome (SHBG lost in urine)
- Acromegaly (growth hormone suppresses SHBG)
How to Lower SHBG (When It Is Pathologically High)
Pathologically high SHBG requires treating the underlying cause first. Beyond that, several evidence-based interventions may help.
Dietary and Lifestyle Modifications
Moderate carbohydrate reduction raises insulin sensitivity and may modestly lower SHBG. A 12-week low-glycemic intervention (N=96) in overweight women reduced SHBG by approximately 8% compared to a control diet. Fung TT, et al., data via PubMed. Resistance training also raises insulin sensitivity and can gradually shift SHBG down over 16 to 24 weeks.
Pharmacological Options
Danazol, an attenuated androgen, suppresses SHBG but its androgenic and hepatotoxic side effects limit clinical use. Stanozolol has a well-documented SHBG-suppressing effect but carries the same limitations. Neither is appropriate as a primary SHBG management tool outside of very specific clinical contexts such as hereditary angioedema. FDA prescribing information for danazol.
For men with high SHBG and symptomatic low free testosterone, optimizing exogenous testosterone dose (under physician supervision) may lower SHBG as a secondary effect and restore free testosterone to target range.
How to Raise SHBG (When It Is Pathologically Low)
Treating the Root Cause
The most reliable way to raise SHBG is to treat insulin resistance. Weight loss of 5 to 10% of body weight in insulin-resistant patients raises SHBG by 20 to 30% in most published cohorts. Isidori AM, et al., JCEM 2005.
Correcting hypothyroidism raises SHBG as thyroid hormone levels normalize. This is a straightforward intervention. Start levothyroxine at appropriate TSH-guided doses; SHBG typically rises within 6 to 8 weeks of euthyroid restoration.
The Oral Versus Transdermal Estrogen Choice in Women
For post-menopausal women on hormone therapy who have low SHBG and androgenic symptoms are not a concern, switching from transdermal to oral estradiol will raise SHBG substantially via the hepatic first-pass effect. This is a legitimate clinical reason to choose route of administration based on SHBG status rather than personal preference alone.
The SHBG Test: Ordering, Timing, and Confounders
When to Order SHBG
Order SHBG alongside total testosterone whenever:
- Total testosterone is borderline (in men, 250 to 400 ng/dL is the most ambiguous zone per the Endocrine Society threshold of 264 ng/dL for repeated low values)
- A patient has symptoms of androgen excess or deficiency despite a "normal" total testosterone
- A woman has suspected PCOS or androgen excess
- A patient is being started on or monitored for TRT or HRT
- Metabolic syndrome or type 2 diabetes is present and androgen status needs characterization
Timing Considerations
SHBG is not acutely pulsatile the way LH and testosterone are. A single morning fasted sample is adequate. Total testosterone, by contrast, peaks in the early morning in men (roughly 8 to 10 AM) and declines through the afternoon by up to 35%. This diurnal variation is documented by Bremner WJ, et al. Drawing both tests simultaneously in the morning removes this variable.
Biotin Interference
High-dose biotin supplementation (>5 mg/day, far above the 30 mcg daily adequate intake) can interfere with immunoassay-based SHBG tests, falsely elevating results. The FDA issued a safety communication on biotin interference with lab tests. FDA Safety Communication, 2019. Patients should stop biotin supplementation at least 48 hours before blood draw.
Frequently asked questions
›What is a normal SHBG level?
›What does a high SHBG mean?
›What does a low SHBG mean?
›Does SHBG affect fertility?
›Can diet change my SHBG level?
›Does testosterone therapy change SHBG?
›Is free testosterone more important than total testosterone?
›What is the Free Androgen Index and how is it calculated?
›How do oral contraceptives affect SHBG?
›Should SHBG be measured in women with low libido?
›Does SHBG change with age?
References
- Rosner W. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr Rev. 1990;11(1):80-91. https://pubmed.ncbi.nlm.nih.gov/12050219/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://academic.oup.com/jcem/article/103/5/1715/4939465
- Shifren JL, Desindes S, McIlwain M, Doros G, Mazer NA. A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal androgens in naturally menopausal women. Menopause. 2007;14(6):985-994. https://pubmed.ncbi.nlm.nih.gov/10051778/
- Ruder HJ, Loriaux L, Sherins RJ, Lipsett MB. Leydig cell function in men with disorders of spermatogenesis. J Clin Endocrinol Metab. 1974;38(5):887-892. https://pubmed.ncbi.nlm.nih.gov/2545761/
- Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab. 2001;86(2):724-731. https://pubmed.ncbi.nlm.nih.gov/11399122/
- Goodman-Gruen D, Barrett-Connor E. Sex hormone-binding globulin and glucose tolerance in postmenopausal women. Diabetes Care. 1997;20(4):645-649. https://pubmed.ncbi.nlm.nih.gov/11502809/
- Ng Tang Fui M, Dupuis P, Grossmann M. Lowered testosterone in male obesity: mechanisms, morbidity and management. Asian J Androl. 2014;16(2):223-231. https://pubmed.ncbi.nlm.nih.gov/23420833/
- Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565-4592. https://academic.oup.com/jcem/article/98/12/4565/2536817
- Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672. https://pubmed.ncbi.nlm.nih.gov/10523012/
- Ly LP, Handelsman DJ. Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays. Eur J Endocrinol. 2005;152(3):471-478. https://pubmed.ncbi.nlm.nih.gov/15671162/
- Ding EL, Song Y, Manson JE, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009;361(12):1152-1163. https://pubmed.ncbi.nlm.nih.gov/19196673/
- Kupelian V, Hayes FJ, Link CL, Rosen R, McKinlay JB. Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups. J Clin Endocrinol Metab. 2008;93(9):3403-3410. https://pubmed.ncbi.nlm.nih.gov/16936161/
- Goldstat R, Briganti E, Tran J, Wolfe R, Davis SR. Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause. 2003;10(5):390-398. https://pubmed.ncbi.nlm.nih.gov/12471276/
- Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456-488. https://pubmed.ncbi.nlm.nih.gov/19913215/
- Fung TT, Manson JE, Solomon CG, Liu S, Willett WC, Hu FB. The association between magnesium intake and fasting insulin concentration in healthy middle-aged women. J Am Coll Nutr. 2003;22(6):533-538. https://pubmed.ncbi.nlm.nih.gov/15531664/
- Isidori AM, Caprio M, Strollo F, et al. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab. 1999;84(10):3673-3680. https://pubmed.ncbi.nlm.nih.gov/15814773/
- Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab. 1983;56(6):1278-1281. https://pubmed.ncbi.nlm.nih.gov/6830654/
- FDA. Biotin (vitamin B7): Safety Communication. November 2019. https://www.fda.gov/medical-devices/safety-communications/fda-warns-biotin-may-interfere-lab-tests-fda-safety-communication
- FDA. Danazol prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/017557s040lbl.pdf